A double-blind placebo-controlled randomized phase II trial assessing the activity and safety of regorafenib in non-adipocytic sarcoma patients previously treated with both chemotherapy and pazopanib

Nicolas Penel, Olivier Mir, Jennifer Wallet, Isabelle Ray‐Coquard, Axel Le Cesne, Antoîne Italiano, Sébastien Salas, Corinne Delcambre, Emmanuelle Bompas, François Bertucci, Esma Saâda-Bouzid, L. Chaigneau, Christine Chevreau, Thomas Brodowicz, Emilie Decoupigny, Marie Vanseymortier, Lucie Laroche, S. Taïeb, Marie‐Cécile Le Deley, Jean‐Yves Blay